Silvia Pandolfi

Silvia Pandolfi is an accomplished expert in the fields of oncology and immunology with extensive experience in research and leadership roles. Currently serving as Head of Target Discovery and Validation at iTeos Therapeutics since April 2022, Silvia previously held key positions at Complix N.V., where responsibilities included managing preclinical research, leading internal programs, and engaging in business development activities from September 2017 to March 2022. Silvia's academic background includes post-doctoral fellowships at VIB and Istituto Toscano Tumori, where significant contributions were made to understanding disease mechanisms, as well as research roles at the National Cancer Institute and Centro per la Ricerca Biomedica Applicata. Silvia earned a PhD in Clinical and Experimental Oncology from Università degli Studi di Firenze and a degree in Pharmaceutical Biotechnology from Alma Mater Studiorum – Università di Bologna.